157 related articles for article (PubMed ID: 36531260)
1. Growth kinetics of multiple
Rivani E; Endraswari PD; Widodo ADW
F1000Res; 2022; 11():762. PubMed ID: 36531260
[No Abstract] [Full Text] [Related]
2. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
3. Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility.
Abbey T; Vialichka A; Jurkovic M; Biagi M; Wenzler E
Microbiol Spectr; 2022 Jun; 10(3):e0054222. PubMed ID: 35647655
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of synergistic activity of antibiotic combinations in extensive drug-resistant
Abdel Halim RM; Saber SM; Fahim NAE
J Med Microbiol; 2023 Feb; 72(2):. PubMed ID: 36762530
[No Abstract] [Full Text] [Related]
5. Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections.
Mohd Sazlly Lim S; Naicker S; Ayfan AK; Zowawi H; Roberts JA; Sime FB
Int J Antimicrob Agents; 2020 Oct; 56(4):106115. PubMed ID: 32721600
[TBL] [Abstract][Full Text] [Related]
6. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Turk Dagi H; Kus H; Arslan U; Tuncer I
Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
[TBL] [Abstract][Full Text] [Related]
7. A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gentamicin and sulbactam.
Chaiben V; Yamada CH; Telles JP; de Andrade AP; Arend LNVS; Ribeiro VST; Dantas LR; Suss PH; Tuon FF
J Antimicrob Chemother; 2022 May; 77(6):1676-1684. PubMed ID: 35368079
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.
Hiraki Y; Yoshida M; Masuda Y; Inoue D; Tsuji Y; Kamimura H; Karube Y; Takaki K; Kawano F
Int J Infect Dis; 2013 Dec; 17(12):e1234-6. PubMed ID: 23791858
[TBL] [Abstract][Full Text] [Related]
9. Semi-mechanistic PK/PD modelling of meropenem and sulbactam combination against carbapenem-resistant strains of Acinetobacter baumannii.
Mohd Sazlly Lim S; Heffernan AJ; Zowawi HM; Roberts JA; Sime FB
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1943-1952. PubMed ID: 33884516
[TBL] [Abstract][Full Text] [Related]
10.
Karlowsky JA; Hackel MA; McLeod SM; Miller AA
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0078122. PubMed ID: 36005804
[TBL] [Abstract][Full Text] [Related]
11. Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an
Beganovic M; Daffinee KE; Luther MK; LaPlante KL
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318006
[No Abstract] [Full Text] [Related]
12. Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia.
Khalili H; Shojaei L; Mohammadi M; Beigmohammadi MT; Abdollahi A; Doomanlou M
J Comp Eff Res; 2018 Sep; 7(9):901-911. PubMed ID: 30192166
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of human intravenous immunoglobulin in combination with antimicrobials and human serum against multidrug-resistant isolates of Acinetobacter baumannii.
de Lima FCG; de Araújo AR; do Nascimento AV; Bezerra Cavalcanti CL; Oliveira Júnior JB; Sandes JM; da Silva EM; de Freitas CF; Veras DL; Alves LC; Brayner FA
Braz J Microbiol; 2023 Dec; 54(4):2845-2856. PubMed ID: 37904004
[TBL] [Abstract][Full Text] [Related]
14. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
Housman ST; Hagihara M; Nicolau DP; Kuti JL
J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
[TBL] [Abstract][Full Text] [Related]
15. Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro.
Güran M; Çakıral K; Teralı K; Kandemir T; Şanlıtürk G; Öcal MM; Nagiyev T; Köksal F
Pathog Dis; 2023 Jan; 81():. PubMed ID: 37120729
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of multidrug-resistant
Sun L; Wang X; Li Z
Br J Neurosurg; 2018 Dec; 32(6):642-645. PubMed ID: 28431478
[No Abstract] [Full Text] [Related]
17. Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant
Petropoulou D; Siopi M; Vourli S; Pournaras S
Front Cell Infect Microbiol; 2021; 11():814530. PubMed ID: 35127562
[TBL] [Abstract][Full Text] [Related]
18.
Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
[TBL] [Abstract][Full Text] [Related]
19. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
[TBL] [Abstract][Full Text] [Related]
20. Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii.
Bian X; Liu X; Feng M; Bergen PJ; Li J; Chen Y; Zheng H; Song S; Zhang J
Int J Antimicrob Agents; 2021 Feb; 57(2):106271. PubMed ID: 33352235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]